SE310676B - - Google Patents

Info

Publication number
SE310676B
SE310676B SE14816/65A SE1481665A SE310676B SE 310676 B SE310676 B SE 310676B SE 14816/65 A SE14816/65 A SE 14816/65A SE 1481665 A SE1481665 A SE 1481665A SE 310676 B SE310676 B SE 310676B
Authority
SE
Sweden
Application number
SE14816/65A
Inventor
M Nakanishi
R Kobayashi
K Arimura
Original Assignee
Yoshitomi Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yoshitomi Pharmaceutical filed Critical Yoshitomi Pharmaceutical
Publication of SE310676B publication Critical patent/SE310676B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/80Acids; Esters in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE14816/65A 1964-11-18 1965-11-16 SE310676B (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP6517864 1964-11-18
JP6285965 1965-10-12

Publications (1)

Publication Number Publication Date
SE310676B true SE310676B (fr) 1969-05-12

Family

ID=26403915

Family Applications (1)

Application Number Title Priority Date Filing Date
SE14816/65A SE310676B (fr) 1964-11-18 1965-11-16

Country Status (9)

Country Link
US (1) US3384642A (fr)
BE (1) BE672385A (fr)
CH (1) CH451143A (fr)
DE (1) DE1620748C3 (fr)
DK (1) DK112383B (fr)
FR (1) FR4854M (fr)
GB (1) GB1131498A (fr)
NL (1) NL6514807A (fr)
SE (1) SE310676B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3479364A (en) * 1967-07-17 1969-11-18 Searle & Co Pyridinecarboxylic acid esters of benzenehexol
AP2005003232A0 (en) 2002-08-19 2005-03-31 Pfizer Prod Inc Combination therapy for hyperproliferative diseases.
US20050037063A1 (en) * 2003-07-21 2005-02-17 Bolton Anthony E. Combined therapies
US20060063803A1 (en) * 2004-09-23 2006-03-23 Pfizer Inc 4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
US7919506B2 (en) 2006-03-10 2011-04-05 Pfizer Inc. Dibenzyl amine compounds and derivatives
ES2382009T3 (es) 2006-12-01 2012-06-04 Bristol-Myers Squibb Company Derivados de N-((3-bencil)-2,2-(bis-fenil-)-propan-1-amina como inhibidores de CETP para el tratamiento de aterosclerosis y enfermedades cardiovasculares
CN105143203A (zh) 2013-04-17 2015-12-09 辉瑞大药厂 用于治疗心血管疾病的n-哌啶-3-基苯甲酰胺衍生物
WO2016055901A1 (fr) 2014-10-08 2016-04-14 Pfizer Inc. Composés d'amide substitué
WO2020150473A2 (fr) 2019-01-18 2020-07-23 Dogma Therapeutics, Inc. Inhibiteurs de pcsk9 et leurs procédés d'utilisation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2863873A (en) * 1956-08-29 1958-12-09 Bofors Ab Esters of nicotinic acid
GB904780A (en) * 1958-05-28 1962-08-29 Exxon Research Engineering Co Manufacture of trimethylol alkanes

Also Published As

Publication number Publication date
DE1620748A1 (de) 1970-05-14
DE1620748C3 (de) 1975-06-19
BE672385A (fr) 1966-05-16
FR4854M (fr) 1967-02-20
US3384642A (en) 1968-05-21
DK112383B (da) 1968-12-09
CH451143A (de) 1968-05-15
NL6514807A (fr) 1966-05-20
GB1131498A (en) 1968-10-23
DE1620748B2 (de) 1974-10-24

Similar Documents

Publication Publication Date Title
FR4854M (fr)
AU4679664A (fr)
BE432268A (fr)
BE47396A (fr)
BE483969A (fr)
BE507097A (fr)
BE518974A (fr)
BE554195A (fr)
BE564626A (fr)
BE584699A (fr)
BE603534A (fr)
BE610935A (fr)
BE613833A (fr)
BE621510A (fr)
BE622126A (fr)
BE623398A (fr)
BE626083A (fr)
BE626684A (fr)
BE627057A (fr)
BE627390A (fr)
BE627931A (fr)
BE628611A (fr)
BE629793A (fr)
BE632875A (fr)
BE636791A (fr)